Compare COR & CVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COR | CVE |
|---|---|---|
| Founded | 2001 | 2009 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.1B | 48.0B |
| IPO Year | 2001 | 2009 |
| Metric | COR | CVE |
|---|---|---|
| Price | $339.53 | $27.79 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 16 |
| Target Price | ★ $371.67 | $37.05 |
| AVG Volume (30 Days) | 1.2M | ★ 6.4M |
| Earning Date | 11-04-2026 | 11-04-2026 |
| Dividend Yield | 0.75% | ★ 2.18% |
| EPS Growth | ★ 5.71 | N/A |
| EPS | ★ 15.21 | N/A |
| Revenue | ★ $321,332,819,000.00 | N/A |
| Revenue This Year | $4.89 | $29.04 |
| Revenue Next Year | $4.35 | N/A |
| P/E Ratio | $23.27 | ★ $18.07 |
| Revenue Growth | ★ 9.31 | N/A |
| 52 Week Low | $244.82 | $15.63 |
| 52 Week High | $377.54 | $34.16 |
| Indicator | COR | CVE |
|---|---|---|
| Relative Strength Index (RSI) | 71.19 | 32.33 |
| Support Level | $299.24 | $27.51 |
| Resistance Level | $375.91 | $30.57 |
| Average True Range (ATR) | 7.60 | 1.11 |
| MACD | 1.04 | -0.39 |
| Stochastic Oscillator | 95.39 | 8.33 |
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Cenovus Energy Inc is a Canadian integrated energy group. The group's upstream operations include oil sands projects in northern Alberta; thermal and conventional crude oil, natural gas, and natural gas liquids (NGLs) projects across Western Canada; crude oil production offshore Newfoundland and Labrador; and natural gas and NGLs production offshore China and Indonesia. Its downstream operations include upgrading and refining operations in Canada and the U.S., and commercial fuel operations across Canada. The group's reportable segments are: Oil Sands, Conventional, Offshore, Canadian Refining, U.S Refining, and Corporate and Eliminations. Maximum revenue is generated from its Oil Sands segment. Geographically, the group derives maximum revenue from the U.S., followed by Canada and China.